Musto, P <br/><br/>
Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.  [electronic resource] 

 -  Haematologica   
 - 493-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0390-6078 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Erythrocytes--pathology<br/>Erythropoiesis<br/>Erythropoietin--therapeutic use<br/>Female<br/>Fluorescence<br/>Humans<br/>Iron--blood<br/>Iron Deficiencies<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--drug therapy<br/>Receptors, Transferrin--analysis<br/>Recombinant Proteins--therapeutic use<br/>Reticulocytes--pathology<br/>Solubility